News
From regular exercise to eating well, there are many things you can do to protect your joints. Try these tips for healthy ...
Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...
Sotyktu significantly improved skin and joint symptoms of psoriatic arthritis and reduced patient-reported disability with no new safety signals. The drug is a first-in-class oral TYK2 inhibitor.
Yoga and strengthening exercises both reduced knee pain in patients with knee ... The program was specifically designed for patients with arthritis, which may not have reflected the safety or ...
With improved knee strength, older adults can take control of their lives with better mobility. Check out these exercises for good joint health. As people grow old, their knee joints grow weaker ...
In addition to being common in active people, knee pain can also be a problem for people with arthritis. While it may be tempting to avoid exercise when knee pain occurs, this is not always the ...
Most of the time, psoriasis is the first symptom of psoriatic arthritis. It causes silvery-white skin lesions called plaques, which may appear on your scalp, elbows, knees, and lower back. Eventually, ...
Among a large cohort of young adults with psoriatic arthritis, 38.8% exhibited radiographic evidence of degenerative disc disease. Researchers in Canada conducted a retrospective cohort study to ...
US-based pharmaceutical company Johnson & Johnson (J&J) has reported positive results from a Phase IIIb trial of its monoclonal antibody Tremfya (guselkumab) for active psoriatic arthritis (PsA).
Patients with psoriatic arthritis (PsA) experienced longer diagnostic delays than matched patients with rheumatoid arthritis (RA). Patients with polyarticular PsA received less intensive disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results